Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1 CNS 1

Conditions

Prostatic Neoplasms 2 Recurrence 1 Melanoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Erythroblastic, Acute 1 Hodgkin Disease 1 Brain Neoplasms 1

Interventions

Temozolomide 73 Bevacizumab 58 Radiotherapy 40 Radiosurgery 28 Carboplatin 23 Nivolumab 17 Etoposide 17 Cisplatin 17 pembrolizumab 16 Irinotecan 16 Ipilimumab 15 Magnetic Resonance Spectroscopy 14 Erlotinib Hydrochloride 14 Cyclophosphamide 14 Carmustine 14 Pemetrexed 13 Topotecan 10 Surgical Procedures, Operative 10 Capecitabine 10 Lapatinib 9 Filgrastim 9 Trastuzumab 8 Thalidomide 8 Sunitinib 8 Paclitaxel 8 Lomustine 8 Aminolevulinic Acid 8 encorafenib 7 binimetinib 7 Vincristine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Brain Neoplasms × Salvage Therapy × Clear all

NCT03340129 2026-02-02

ABC-X

Melanoma Institute Australia

Phase 2 Recruiting

CNSDermatologic

Brain Neoplasms, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡